British Journal of Clinical Pharmacology

Editorial for BJCP Special Obesity Edition
pp. 801-803(3)
Author: Park, Adrian

Pharmacotherapy for obesity
pp. 804-810(7)
Authors: Li, Mingfang; Cheung, Bernard M. Y.

Recent progress in the genetics of common obesity
pp. 811-829(19)
Author: Loos, Ruth J. F.

Obesity treatment: novel peripheral targets
pp. 830-843(14)
Authors: Field, Benjamin C. T.; Chaudhri, Owais B.; Bloom, Stephen R.

Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study
pp. 844-851(8)
Authors: Viner, Russell M.; Hsia, Yingfen; Neubert, Antje; Wong, Ian C. K.

New central targets for the treatment of obesity
pp. 852-860(9)
Authors: Sargent, Bruce J.; Moore, Nicholas A.

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders
pp. 861-874(14)
Authors: Heal, David J.; Gosden, Jane; Smith, Sharon L.

Metformin increases plasma ghrelin in Type 2 diabetes
pp. 875-882(8)
Authors: Doogue, Matthew P.; Begg, Evan J.; Moore, M. Peter; Lunt, Helen; Pemberton, Chris J.; Zhang, Mei

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
pp. 883-890(8)
Authors: Lim, Kyoung Soo; Cho, Joo-Youn; Kim, Bo-Hyung; Kim, Jung-Ryul; Kim, Hwa-Sook; Kim, Dong-Kyu; Kim, Sung-Ho; Yim, Hyeon Joo; Lee, Sung-Hack; Shin, Sang-Goo; Jang, In-Jin; Yu, Kyung-Sang

Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients
pp. 891-897(7)
Authors: Pereira, S. A.; Batuca, J. R.; Caixas, U.; Branco, T.; Delgado-Alves, J.; Germano, I.; Lampreia, F.; Monteiro, E. C.

Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
pp. 898-905(8)
Authors: Jacobsen, Lisbeth V.; Hindsberger, Charlotte; Robson, Richard; Zdravkovic, Milan

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
pp. 906-915(10)
Authors: Scholz, Ina; Oberwittler, Heike; Riedel, Klaus-Dieter; Burhenne, Jürgen; Weiss, Johanna; Haefeli, Walter E.; Mikus, Gerd

Relationship between blood alcohol concentration on admission and outcome in dimethoate organophosphorus self-poisoning
pp. 916-919(4)
Authors: Eddleston, Michael; Gunnell, David; von Meyer, Ludwig; Eyer, Peter

Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase
pp. 920-927(8)
Authors: Greenblatt, David J.; Peters, Diane E.; Oleson, Lauren E.; Harmatz, Jerold S.; MacNab, Malcolm W.; Berkowitz, Noah; Zinny, Miguel A.; Court, Michael H.

Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A
pp. 928-935(8)
Authors: Turpault, Sandrine; Brian, William; Van Horn, Robert; Santoni, Alix; Poitiers, Franck; Donazzolo, Yves; Boulenc, Xavier

Potentially inappropriate prescribing in an Irish elderly population in primary care
pp. 936-947(12)
Authors: Ryan, Cristín; O'Mahony, Denis; Kennedy, Julia; Weedle, Peter; Byrne, Stephen

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study
pp. 948-955(8)
Authors: Beghetti, Maurice; Haworth, Sheila G.; Bonnet, Damien; Barst, Robyn J.; Acar, Philippe; Fraisse, Alain; Ivy, Dunbar D.; Jais, Xavier; Schulze-Neick, Ingram; Galiè, Nazzareno; Morganti, Adele; Dingemanse, Jasper; Kusic-Pajic, Andjela; Berger, Rolf M. F.

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations
pp. 956-962(7)
Authors: Matok, Ilan; Gorodischer, Rafael; Koren, Gideon; Landau, Daniella; Wiznitzer, Arnon; Levy, Amalia

Self report may lead to underestimation of `wrong dose' medication errors
pp. 963-964(2)
Authors: Kiekkas, Panagiotis; Aretha, Diamanto; Karga, Mary; Karanikolas, Menelaos

Introduction to Neuropsychopharmacology
pp. 965-965(1)
Author: Szabadi, Elemer

Translation Section
pp. 966-973(8)